PL355171A1 - Etery 0-demetylowenlafaksyny - Google Patents
Etery 0-demetylowenlafaksynyInfo
- Publication number
- PL355171A1 PL355171A1 PL00355171A PL35517100A PL355171A1 PL 355171 A1 PL355171 A1 PL 355171A1 PL 00355171 A PL00355171 A PL 00355171A PL 35517100 A PL35517100 A PL 35517100A PL 355171 A1 PL355171 A1 PL 355171A1
- Authority
- PL
- Poland
- Prior art keywords
- ethers
- desmethyl venlafaxine
- desmethyl
- venlafaxine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C217/74—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Addiction (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Gynecology & Obstetrics (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Furan Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US44826899A | 1999-11-24 | 1999-11-24 |
Publications (2)
Publication Number | Publication Date |
---|---|
PL355171A1 true PL355171A1 (pl) | 2004-04-05 |
PL202846B1 PL202846B1 (pl) | 2009-07-31 |
Family
ID=23779642
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL355171A PL202846B1 (pl) | 1999-11-24 | 2000-11-21 | Etery O-desmetylowenlafaksyny, sposób ich wytwarzania oraz kompozycja farmaceutyczna zawierająca te związki |
Country Status (25)
Country | Link |
---|---|
EP (1) | EP1232141B1 (pl) |
JP (1) | JP2003514889A (pl) |
KR (1) | KR100843991B1 (pl) |
CN (2) | CN1198793C (pl) |
AR (1) | AR024498A1 (pl) |
AT (1) | ATE278659T1 (pl) |
AU (1) | AU767835B2 (pl) |
BR (1) | BR0015795A (pl) |
CA (1) | CA2391288A1 (pl) |
CZ (1) | CZ20021816A3 (pl) |
DE (1) | DE60014693T2 (pl) |
DK (1) | DK1232141T3 (pl) |
ES (1) | ES2228636T3 (pl) |
HK (1) | HK1045835A1 (pl) |
HU (1) | HUP0203594A2 (pl) |
IL (2) | IL149531A0 (pl) |
MX (1) | MXPA02005174A (pl) |
NO (1) | NO20022446L (pl) |
NZ (1) | NZ519130A (pl) |
PL (1) | PL202846B1 (pl) |
PT (1) | PT1232141E (pl) |
SI (1) | SI1232141T1 (pl) |
TW (1) | TWI268919B (pl) |
WO (1) | WO2001038293A1 (pl) |
ZA (1) | ZA200204986B (pl) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6602911B2 (en) * | 2001-11-05 | 2003-08-05 | Cypress Bioscience, Inc. | Methods of treating fibromyalgia |
PT2621891T (pt) * | 2010-10-01 | 2020-02-04 | Shan Dong Luye Pharm Co Ltd | Polimorfos de cloridrato de 4-metilbenzoato de 4-[2- dimetilamino-1-(1-hidroxiciclohexil)etil]fenilo, métodos para a preparação dos mesmos e utilização dos mesmos |
CN103319373B (zh) * | 2012-03-23 | 2017-09-19 | 浙江九洲药业股份有限公司 | 1‑[2‑氨基‑1‑(4‑苄氧基苯基)乙基]环己烷醇的制备方法及相关中间体 |
-
2000
- 2000-11-21 ES ES00980588T patent/ES2228636T3/es not_active Expired - Lifetime
- 2000-11-21 WO PCT/US2000/031895 patent/WO2001038293A1/en active IP Right Grant
- 2000-11-21 AT AT00980588T patent/ATE278659T1/de not_active IP Right Cessation
- 2000-11-21 MX MXPA02005174A patent/MXPA02005174A/es active IP Right Grant
- 2000-11-21 EP EP00980588A patent/EP1232141B1/en not_active Expired - Lifetime
- 2000-11-21 IL IL14953100A patent/IL149531A0/xx unknown
- 2000-11-21 NZ NZ519130A patent/NZ519130A/en unknown
- 2000-11-21 CA CA002391288A patent/CA2391288A1/en not_active Abandoned
- 2000-11-21 CN CNB008161496A patent/CN1198793C/zh not_active Expired - Fee Related
- 2000-11-21 KR KR1020027006602A patent/KR100843991B1/ko not_active IP Right Cessation
- 2000-11-21 PT PT00980588T patent/PT1232141E/pt unknown
- 2000-11-21 DK DK00980588T patent/DK1232141T3/da active
- 2000-11-21 DE DE60014693T patent/DE60014693T2/de not_active Expired - Fee Related
- 2000-11-21 BR BR0015795-3A patent/BR0015795A/pt active Pending
- 2000-11-21 SI SI200030509T patent/SI1232141T1/xx unknown
- 2000-11-21 CZ CZ20021816A patent/CZ20021816A3/cs unknown
- 2000-11-21 CN CNA2004100882450A patent/CN1636559A/zh active Pending
- 2000-11-21 PL PL355171A patent/PL202846B1/pl not_active IP Right Cessation
- 2000-11-21 HU HU0203594A patent/HUP0203594A2/hu unknown
- 2000-11-21 AU AU17833/01A patent/AU767835B2/en not_active Ceased
- 2000-11-21 JP JP2001539850A patent/JP2003514889A/ja not_active Withdrawn
- 2000-11-22 AR ARP000106165A patent/AR024498A1/es unknown
- 2000-11-23 TW TW089124917A patent/TWI268919B/zh not_active IP Right Cessation
-
2002
- 2002-05-08 IL IL149531A patent/IL149531A/en not_active IP Right Cessation
- 2002-05-23 NO NO20022446A patent/NO20022446L/no not_active Application Discontinuation
- 2002-06-20 ZA ZA200204986A patent/ZA200204986B/en unknown
- 2002-10-09 HK HK02107379A patent/HK1045835A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DE60014693T2 (de) | 2005-03-10 |
CN1399626A (zh) | 2003-02-26 |
NO20022446D0 (no) | 2002-05-23 |
AU1783301A (en) | 2001-06-04 |
KR100843991B1 (ko) | 2008-07-07 |
AU767835B2 (en) | 2003-11-27 |
EP1232141B1 (en) | 2004-10-06 |
IL149531A0 (en) | 2002-11-10 |
NZ519130A (en) | 2003-09-26 |
DE60014693D1 (en) | 2004-11-11 |
JP2003514889A (ja) | 2003-04-22 |
CN1198793C (zh) | 2005-04-27 |
MXPA02005174A (es) | 2002-11-07 |
HK1045835A1 (en) | 2002-12-13 |
CA2391288A1 (en) | 2001-05-31 |
ES2228636T3 (es) | 2005-04-16 |
AR024498A1 (es) | 2002-10-02 |
SI1232141T1 (en) | 2004-12-31 |
CZ20021816A3 (cs) | 2002-08-14 |
IL149531A (en) | 2008-12-29 |
EP1232141A1 (en) | 2002-08-21 |
KR20030058931A (ko) | 2003-07-07 |
ZA200204986B (en) | 2003-09-27 |
ATE278659T1 (de) | 2004-10-15 |
WO2001038293A1 (en) | 2001-05-31 |
PT1232141E (pt) | 2004-12-31 |
CN1636559A (zh) | 2005-07-13 |
PL202846B1 (pl) | 2009-07-31 |
NO20022446L (no) | 2002-05-23 |
HUP0203594A2 (en) | 2003-02-28 |
DK1232141T3 (da) | 2004-11-29 |
TWI268919B (en) | 2006-12-21 |
BR0015795A (pt) | 2002-07-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0105096A3 (en) | Preparation of iodixanol | |
HUP0402269A3 (en) | Methods for preparing o-desmethylvenlafaxine | |
AU2002364517A1 (en) | Tramadol analogs and uses thereof | |
GB9912356D0 (en) | Generation of microfoam | |
AU5738700A (en) | Enantiomers of o-desmethyl venlafaxine | |
PL368600A1 (pl) | Sposób otrzymywania tolterodyny | |
EP1169466A4 (en) | SYNTHESIS OF 1,2,3,4-TETRAHYDROXYBENZOLE AND 1,2,3-TRIHYDROXYBENZOLENE BY MYO-INOSITOL-1-PHOSPHATE SYNTHASE AND MYO-INOSITOL-2-DEHYDROGENASE | |
AU9178501A (en) | Process for the preparation of substituted phenylacetonitriles | |
HK1042036A1 (zh) | 鈣溶解化合物 | |
HUP0202167A3 (en) | Calcilytic compounds | |
IL149531A0 (en) | Ethers of o-desmethyl venlafaxine | |
AU2002322326A1 (en) | Tolterodine metabolites | |
IL136957A0 (en) | Purification of tramadol | |
AU2629599A (en) | Purification of tramadol | |
GB0127100D0 (en) | Elastic support band | |
TW512678U (en) | Improved structure of integrally-formed bra | |
AU3464P (en) | STRGRA Magnolia grandiflora | |
AU4271P (en) | MGTIG Magnolia grandiflora | |
AU4189P (en) | TMGH Magnolia grandiflora | |
AU3339P (en) | JURmag1 Magnolia xsoulangeana | |
AU3340P (en) | JURmag2 Magnolia xsoulangeana | |
TW535509U (en) | Improved structure of bra | |
TW533817U (en) | Assembly structure of elastic strip of chair | |
AU2003200051A1 (en) | Respiratory Mask Assembly | |
TW468439U (en) | Structure of assembly triangular frame |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
LAPS | Decisions on the lapse of the protection rights |
Effective date: 20091121 |